Delivery Order SPE2DB20D2104-SPE2DB26FMALG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,742.45. This competitively awarded, non-set-aside contract was executed on September 9, 2025, with an ultimate completion date of September 10, 2025, and reflects a firm fixed price arrangement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $14,078.17 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s with a ceiling value of $3,646.02. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on September 2, 2025, with a final delivery date of September 3, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s under a firm fixed price contract. The award, dated August 13, 2025, carries a ceiling value of $3,207.05 with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, indicating competitive award. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s under a firm fixed-price contract with a ceiling value of $4,525.38. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under a larger vehicle. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $3,402.60. This is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, executed through AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $4,961.89. This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units, with a ceiling value of $2,188.92. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $17,105.21 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office as a leading pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lidocaine 5% Patch 30-count units. This competitively awarded, non-set-aside contract carries a ceiling value of $14,015.61 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 11, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMALGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30S with a ceiling value of $1,358.91. The contract is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, and was awarded on October 20, 2025. This award carries no set-aside designation and represents a competitive award under AmerisourceBergen's existing contract vehicle with the DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Lidocaine patches are topical pain management products commonly used within military and veteran healthcare systems, consistent with the company's portfolio of pain management pharmaceuticals delivered through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/20/25 |